Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641172-25-004770
Filing Date
2025-04-15
Accepted
2025-04-15 15:44:46
Documents
1
Effectiveness Date
2025-04-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8199
  Complete submission text file 0001641172-25-004770.txt   9478
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-543765 | Film No.: 25839357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)